Blog

Advancing Hemp Breeding with PACE® Genotyping: Insights from the Smart Lab at Cornell University

Advancing Hemp Breeding with PACE® Genotyping: Insights from the Smart Lab at Cornell University

At the School of Integrative Plant Science, Cornell AgriTech, Geneva, NY, Professor Larry Smart and his team are pioneering the integration of molecular genetics into hemp (Cannabis sativa) breeding. Originally focused on willow genetics for bioenergy, the Smart Lab pivoted in 2017 to hemp—an emerging crop with remarkable diversity and rapidly evolving markets. Their research now focuses on understanding and improving traits such as:

  • Cannabinoid profile
  • Plant sex determination
  • Flowering time and photoperiod sensitivity
  • Seed size and plant architecture
  • Disease and pest resistance (e.g. powdery mildew)

By combining commercial cultivar evaluation, segregating population development, SNP genotyping platforms, and high-throughput phenotyping, the team delivers improved cultivars designed to meet the needs of growers and industry.

The Role of SNP Genotyping in Hemp Breeding

Many key traits in hemp only appear late in development or under specific environments, complicating early selection. To address this, the Smart Lab applies single SNP genotyping, which enables them to:

  • Select for traits early in the breeding cycle
  • Determine allelic status for recessive loci
  • Fine-map genes of interest
  • Stack genes difficult to distinguish phenotypically

This approach accelerates breeding, reduces costs, and improves cultivar uniformity—critical for large-scale commercial hemp production.

PACE® Technology: A Practical Solution for Breeders

PACE is a robust, low-cost, high-throughput genotyping chemistry that is central to Cornell’s hemp program. With relatively low startup requirements — validated marker assays, scalable DNA extraction, and qPCR or fluorescent plate reader equipment — PACE is uniquely suited for applied breeding research.

Example showing PACE assay output, with samples clustering into three genotypic groups

Applications in Hemp Breeding

Early Sex Determination

  • PACE assays distinguish male (XY) from female (XX) plants before flowering.
  • Enables  efficient   management of breeding populations and crossing blocks.

“Supermale” Viability Testing

  • Chromosome ratio assays revealed that YY plants are non-viable.
  • Only XX and XY genotypes persist in populations derived from XY parents.

Flowering Time Genetics

  • PACE markers allow early identification of homozygous and heterozygous states at major flowering loci.
  • Supports development of uniform cultivars and earlier prediction of photoperiod sensitivity.

Chemotype Determination

  • PACE assays replace slow, costly HPLC analysis, providing rapid and reliable identification of cannabinoid types.
  • Ensures compliance with legal THC thresholds during breeding.

Case Study: Optimising the Bnull Marker

The Bnull haplotype, associated with chemotype IV plants, results from a 120 kb deletion of CBDAS at the B-locus. Traditional detection requires labour- intensive HPLC or gel-based assays. The Smart Lab have developed and optimised PACE assays to:

  • Reliably detect the deletion with high specificity
  • Enable marker-assisted selection (MAS) of over 1,500 seedlings
  • Verify cannabinoid-null phenotypes with follow-up HPLC, confirming the absence of THCA and CBDA

Staked, numbered C. sativa seedlings. Leaves have been collected and DNA extracted for marker testing.

Automation of Marker Assays

To further increase efficiency and consistency, the Smart Lab has automated key steps of the PACE genotyping workflow using an Agilent Bravo liquid- handling robot. The system performs both DNA extraction and PACE assay setup in 96- or 384-well plate formats. This automation enables high- throughput screening of over 3,000 samples per week—from seedling tissue collection to genotype calls—with minimal manual bench time. This expanded throughput enables the selection and scale-up of low-frequency alleles that would otherwise be too rare to capture and advance in breeding populations.

Agilent Bravo liquid-handling robot extracting DNA from dried hemp leaf samples to be used for PACE molecular marker screening.

Getting Started with PACE®

Design:

Identify trait-linked SNPs or InDels and design primers using the universal 5′ tail system. The competitive primers should anchor the polymorphism at the 3′ end. The shared common primer should be free of any known polymorphisms.

Ideal binding site parameters:

  • Tm = 57-65 °C
  • GC-content = 40-60 %
  • Product length = 60–120 bp

Bio-Rad qPCR machine set up to run prepared PACE assay in a 384-well plate.

DNA Quality:

For hemp and most plant species, CTAB-extracted DNA provides reliable template quality. PACE assays are tolerant of moderate DNA quality variation, and crude preps can perform well provided that PCR inhibitors are minimised.

Instrumentation:

PACE reactions require a thermocycler and are compatible with qPCR systems or fluorescence plate readers capable of detecting FAM and HEX wavelengths.

Validation:

Validate each assay using known genotypes representing all three allelic configurations (homozygous reference, heterozygous, homozygous alternate) to confirm accurate clustering. Once validated, these samples can be retained as internal controls for future assay runs.

Validated Marker Portfolio

The Smart Lab has developed and validated a growing panel of molecular markers for hemp traits, which are available on their Cornell Hemp GitHub repository, including:

  • Chemotype: Multiple assays distinguishing THCAS, CBDAS, and null alleles
  • Flowering time: SNP and duplication events linked to day-neutral and early flowering phenotypes
  • Sex determination: Diagnostic markers distinguishing XX vs. XY
  • Disease resistance: Markers linked to powdery mildew susceptibility genes
  • Pigmentation: Markers for purple leaves, stems, and flowers

This marker set, validated across diverse germplasm, enables reproducible high-throughput genotyping for both breeding and population-level surveys.

Examples of PACE-validated trait markers in hemp.

Benefits of PACE® for Hemp Breeding

The Smart Lab highlights several advantages of PACE genotyping across breeding programs:

  • Clear, interpretable clustering of results
  • Flexible scalability from hundreds to tens of thousands of samples
  • Affordable implementation compared to alternative platforms
  • Diagnostic-level accuracy across diverse populations
  • Ease of new marker creation with the universal 5’ tail system

Future Directions

The Smart Lab continues to expand their genotyping toolkit with PACE technology, focusing on:

  • Improving markers to diagnostic-level accuracy
  • Developing new trait assays as genomic resources expand
  • Multiplexing PACE assays to increase throughput and reduce costs further.

Conclusion

The hemp genetics program led by Professor Larry Smart at Cornell AgriTech is advancing plant breeding by integrating molecular genetics, high-throughput phenotyping, and PACE genotyping technology.

By enabling early, accurate, and affordable selection for critical traits—including sex, chemotype, flowering time, and disease resistance— PACE empowers breeders to shorten breeding cycles, cut costs, and deliver superior cultivars to market faster.

PACE has become a valuable tool in modern hemp breeding, supporting innovation in breeding programs worldwide.

MORE POSTS

Advancing Hemp Breeding with PACE® Genotyping: Insights from the Smart Lab at Cornell University
Researchers have developed a rapid, PACE-validated sex-marker panel for Tambaqui, enabling fast and accurate gender identification to boost efficiency and genetic gains in aquaculture breeding programs.
Early, rapid sex-linked markers for Colossoma macropomum, the Amazon Tambaqui
Researchers have developed a rapid, PACE-validated sex-marker panel for Tambaqui, enabling fast and accurate gender identification to boost efficiency and genetic gains in aquaculture breeding programs.
Developing molecular techniques for enhanced cereal varieties at The Field Crop Development Centre
Discover how PACE genotyping streamlines marker-assisted selection and accelerates the development of high-performing cereal varieties.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

MEET OUR TEAM

Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.